WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke QUAISAR Drug Design Platform wurde als Wortmarke am 20.01.2023 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1720661 |
| Registernummer | 789504 |
| Länder | 
|
| Basismarke |
Nr. 789504,
26. Juli 2022
|
| Anmeldedatum | 20. Januar 2023 |
| Ablaufdatum | 20. Januar 2033 |
Markeninhaber
Viaduktstrasse 8
4051 Basel
CH
4051 Basel
CH
Markenvertreter
151 W 42nd St, 17th Floor
New York NY 10036
US
Waren und Dienstleistungen
09
Computer software; computer software for providing,
analyzing and generating reports; computer software for data
processing; electronic apparatus, electronic equipment,
software, programs and systems for the capture, collection,
conversion, analysis, communication, processing, receiving,
recording, storage and/or transmission of data, images and
information; computer software for database integration;
downloadable and recorded software for collecting,
analyzing, reporting, and tracking data and information in
the fields of drug discovery and development, genetics,
genomics, biology, biochemistry; downloadable and recorded
software for genetic assessment and identification of
diseases, health status and metrics, and gene mutations for
scientific, medical, diagnostic, treatment, and research
purposes; downloadable and recorded software to diagnose
medical conditions, to prescribe medical treatment and
prescriptions, to design clinical trials and forecast
clinical trial results, to search for clinical trial
patients, to analyze medical data and images, to analyze
data, and to develop pharmaceutical products and chemical
compounds; downloadable and recorded software for
collecting, analyzing, reporting, and tracking data and
information in the fields of clinical trial management and
patient engagement
42
Scientific and technological services and research and
design relating thereto; Analysis of technical data by
computers; pharmaceutical drug discovery services;
Pharmaceutical and biotechnology research and development
services; drug use discovery services; design and
development of pharmaceutical preparations and medicines;
research and development in the field of drug discovery;
conducting scientific and pharmaceutical research and data
analysis to screen for and identify molecular interactions,
compounds and detect toxicity; providing scientific,
pharmaceutical and agrochemical database research services;
scientific and pharmaceutical artificial intelligence
research services to identify molecules and compounds for
drug discovery and chemical development; bioinformatics
services, namely, using the combination of biology, computer
science, information engineering, mathematics and statistics
to analyze and interpret biological data; computer-assisted
molecule design; identification of biological targets,
networks and pathways; biological research and analysis;
pharmaceutical research and development services;
computer-aided diagnostic and screening services for
scientific research purposes; contract research services in
support of scientific research and development of
pharmaceutical preparations; software as a service (SaaS)
featuring software to diagnose medical conditions, to
prescribe medical treatment and prescriptions, to design
clinical trials and forecast clinical trial results, to
search for clinical trial patients, to analyze medical
images, to analyze data, and to develop pharmaceutical
products and chemical compounds; software as a service for
collecting, analyzing, reporting, and tracking data and
information in the fields of drug discovery and development,
genetics, genomics, biology and biochemistry; software as a
service for collecting, analyzing, reporting, and tracking
data and information in the fields of clinical trial
management and patient engagement
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 24. März 2023 | 2023/14 Gaz | EM | Ablehnung |
| 20. Januar 2023 | 2023/10 Gaz | CH | Eintragung |
ID: 141720661